About DSI InPharmatics
DSI InPharmatics is a Healthcare company based in Harleysville (United States) founded in 2007, and was acquired by ProductLife Group in May 2021. Full-service CMC consulting for drug and biologic development is provided. DSI InPharmatics offers products and services including Regulatory Affairs Consulting, CMC Services, Quality Assurance, and Project Management. Its focus areas include Biopharma Outsourcing, Consulting and Regulatory Affairs. Its competitors include ProPharma Group, Validant and Technical Safety Services; 1 of its 3 listed competitors has raised funding.
Company details
DSI InPharmatics is a provider of one-stop, full-service CMC consulting services for the development of drugs and biologics to the pharmaceutical and biotech companies. Their services include the design of development and operation plans, SOP and protocol implementation, gap and risk identification, virtual QA and data interpretation, product manufacturing and testing, statistics, and GMP, GCP regulatory compliance. DSI claims to have experience in the development of protein based therapeutics (MAbs, biosimilars, recombinant proteins, drug conjugates and others), small molecules (NCEs, generics, cytokines, and peptides) and in a wide range of dosage forms (including solid, liquid, parenteral injections (liquid and lyophilized), inhalation, transdermal patches, and gels.
- Headquarters Harleysville, United States
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website dsinpharmatics.com
- Social LinkedIn X YouTube
- Acquired by ProductLife Group (May 2021)
- Investors
- Acquired byProductLife Group
(May 2021)
Products & Services of DSI InPharmatics
DSI InPharmatics offers a comprehensive portfolio of products and services, including Regulatory Affairs Consulting, CMC Services, Quality Assurance, and Project Management.
Assists with regulatory submissions and agency interactions for drug approvals.
Supports chemistry, manufacturing, and controls for pharmaceutical products.
Ensures quality systems and compliance in drug development processes.
Manages development programs from preclinical to post-approval stages.
Apps and channels of DSI InPharmatics
its YouTube channel DS InPharmatics has 218 subscribers and 26 videos.
Videos from DSI InPharmatics
The most watched videos on DSI InPharmatics's YouTube channel, DS InPharmatics (218 subscribers). Click a video to play it here.
More on DS InPharmatics.
Investors in DSI InPharmatics
DSI InPharmatics has secured backing from 1 investor. Prominent investors backing the company include ProductLife Group.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Regulatory and pharmacovigilance support is provided for product lifecycles. | 2000 | productlifegroup.com | Suresnes, France |
Investor details for DSI InPharmatics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of DSI InPharmatics
5 people are tracked at DSI InPharmatics (4 in leadership, 1 in team).
| Name | Role | Group |
|---|---|---|
Robert Gaffney | Head Of Recruitment Operations | Leadership |
Bettina Kaplan | Head Of Quality Assurance Services | Leadership |
Meranda Parascandola | Head Of Marketing And Sales Analytics | Leadership |
Colman Byrne | Head Of Analytical Services | Leadership |
Susan Fasso | Senior Quality Assurance Consultant | Team |
Complete people profiles for DSI InPharmatics
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of DSI InPharmatics
2 dated milestones of DSI InPharmatics across 14 years, from founding to its latest funding, stage changes and deals.
- Founded DSI InPharmatics is founded.
- Exit Acquired by ProductLife Group.
Competitors of DSI InPharmatics
DSI InPharmatics has 3 listed competitors in our database, 1 of them funded. They include ProPharma Group, Validant and Technical Safety Services.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| propharmagroup.com | 2001 | Saint Paul, United States | 999 | Provider of regulatory compliance solutions to pharmaceutical, biotechnology and medical device | ||
| validant.com | 2005 | San Francisco, United States | $2.28M | Regulatory, compliance, and quality consulting for GxP lifecycles is provided. | ||
| techsafety.com | 1970 | Berkeley, United States | 71 | Healthcare instrumentation, medical gas systems, and related devices are manufactured. |
Detailed competitors of DSI InPharmatics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of DSI InPharmatics
The website of DSI InPharmatics (dsinpharmatics.com) receives about 2.4K visits a month.
- Monthly visits2.4K
▲ 25.4% vs previous month
Websites whose visitors overlap most with DSI InPharmatics. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
mail.google.com | mail.google.com | 100% | – | ||
jalexmedical.com | jalexmedical.com | 92% | #14,925,065 | – | |
pharmdevgroup.com | pharmdevgroup.com | 92% | #8,792,100 | – | |
| veristat.com | 91% | 11.2K | #2,455,321 | View details | |
intrinsik.com | intrinsik.com | 91% | #5,885,917 | – | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 16 similar websites and full traffic analytics for DSI InPharmatics
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 16 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as DSI InPharmatics (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 5,666 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about DSI InPharmatics
DSI InPharmatics was founded in 2007.
DSI InPharmatics is headquartered in Harleysville, United States. It is registered at Harleysville, Pennsylvania, United States.
DSI InPharmatics is a provider of one-stop, full-service CMC consulting services for the development of drugs and biologics to the pharmaceutical and biotech companies. Their services include the design of development and operation plans, SOP and protocol implementation, gap and risk identification, virtual QA and data interpretation, product manufacturing and testing, statistics, and GMP, GCP regulatory compliance. DSI claims to have experience in the development of protein based therapeutics (MAbs, biosimilars, recombinant proteins, drug conjugates and others), small molecules (NCEs, generics, cytokines, and peptides) and in a wide range of dosage forms (including solid, liquid, parenteral injections (liquid and lyophilized), inhalation, transdermal patches, and gels.
DSI InPharmatics's top competitors include ProPharma Group, Validant and Technical Safety Services.
DSI InPharmatics offers Regulatory Affairs Consulting, CMC Services, Quality Assurance, and Project Management.
DSI InPharmatics has 1 investor. Key investors include ProductLife Group.
Yes. DSI InPharmatics was acquired by ProductLife Group in May 2021.